vs
Side-by-side financial comparison of CervoMed Inc. (CRVO) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
CervoMed Inc. is the larger business by last-quarter revenue ($1.8M vs $919.3K, roughly 1.9× Laser Photonics Corp). CervoMed Inc. runs the higher net margin — -356.1% vs -506.4%, a 150.4% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs -46.6%). Over the past eight quarters, CervoMed Inc.'s revenue compounded faster (7.3% CAGR vs -3.9%).
CervoMed Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurodegenerative conditions such as Alzheimer’s disease and other forms of dementia. It operates in the global biopharmaceutical market, with core R&D segments dedicated to addressing unmet medical needs for patients with progressive brain disorders.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
CRVO vs LASE — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8M | $919.3K |
| Net Profit | $-6.3M | $-4.7M |
| Gross Margin | — | -20.1% |
| Operating Margin | -376.4% | -350.0% |
| Net Margin | -356.1% | -506.4% |
| Revenue YoY | -46.6% | 28.3% |
| Net Profit YoY | -170.1% | -186.5% |
| EPS (diluted) | — | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $919.3K | ||
| Q2 25 | $1.8M | $2.6M | ||
| Q1 25 | $1.9M | $2.3M | ||
| Q4 24 | $2.2M | $1.3M | ||
| Q3 24 | $1.9M | $716.7K | ||
| Q2 24 | $3.3M | $623.4K | ||
| Q1 24 | $2.3M | $743.0K | ||
| Q4 23 | $2.5M | $994.6K |
| Q3 25 | — | $-4.7M | ||
| Q2 25 | $-6.3M | $-1.8M | ||
| Q1 25 | $-4.9M | $-1.7M | ||
| Q4 24 | $-6.7M | $586.4K | ||
| Q3 24 | $-4.8M | $-1.6M | ||
| Q2 24 | $-2.3M | $-934.3K | ||
| Q1 24 | $-2.5M | $-545.7K | ||
| Q4 23 | $-2.4M | $-486.6K |
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% | ||
| Q4 23 | — | 84.5% |
| Q3 25 | — | -350.0% | ||
| Q2 25 | -376.4% | -37.0% | ||
| Q1 25 | -276.6% | -68.7% | ||
| Q4 24 | -334.9% | -255.1% | ||
| Q3 24 | -278.2% | -238.0% | ||
| Q2 24 | -91.1% | -149.4% | ||
| Q1 24 | -110.6% | -73.8% | ||
| Q4 23 | -99.6% | -88.4% |
| Q3 25 | — | -506.4% | ||
| Q2 25 | -356.1% | -68.3% | ||
| Q1 25 | -255.2% | -73.4% | ||
| Q4 24 | -310.2% | 45.7% | ||
| Q3 24 | -245.1% | -226.8% | ||
| Q2 24 | -70.4% | -149.9% | ||
| Q1 24 | -107.1% | -73.4% | ||
| Q4 23 | -94.9% | -48.9% |
| Q3 25 | — | $-0.27 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-0.55 | $-0.13 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.06 | ||
| Q4 23 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.5M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $33.4M | $4.1M |
| Total Assets | $38.1M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $3.6M | ||
| Q2 25 | $33.5M | $78.5K | ||
| Q1 25 | $35.2M | $179.1K | ||
| Q4 24 | $38.9M | $533.9K | ||
| Q3 24 | $46.7M | $2.1M | ||
| Q2 24 | $45.1M | $2.7M | ||
| Q1 24 | $6.4M | $5.2M | ||
| Q4 23 | $7.8M | $6.2M |
| Q3 25 | — | $4.1M | ||
| Q2 25 | $33.4M | $4.3M | ||
| Q1 25 | $34.6M | $6.8M | ||
| Q4 24 | $39.2M | $10.2M | ||
| Q3 24 | $45.6M | $9.7M | ||
| Q2 24 | $50.0M | $10.3M | ||
| Q1 24 | $5.3M | $12.4M | ||
| Q4 23 | $7.4M | $13.9M |
| Q3 25 | — | $17.5M | ||
| Q2 25 | $38.1M | $14.9M | ||
| Q1 25 | $38.6M | $16.0M | ||
| Q4 24 | $43.1M | $17.2M | ||
| Q3 24 | $48.9M | $10.6M | ||
| Q2 24 | $53.2M | $11.1M | ||
| Q1 24 | $8.0M | $13.6M | ||
| Q4 23 | $10.0M | $15.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.5M | $763.1K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $763.1K | ||
| Q2 25 | $-6.5M | $-1.0M | ||
| Q1 25 | $-3.9M | $-1.2M | ||
| Q4 24 | $-8.1M | $-6.5M | ||
| Q3 24 | $-4.9M | $632.7K | ||
| Q2 24 | $-2.2M | $-2.4M | ||
| Q1 24 | $-1.4M | $-866.3K | ||
| Q4 23 | $-2.5M | $-2.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-1.0M | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
